Florina Borca
Overview
Explore the profile of Florina Borca including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
296
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang T, Campbell C, Stockdale A, Todd S, McIntyre K, Frankland A, et al.
JHEP Rep
. 2024 Dec;
7(1):101229.
PMID: 39717508
Background & Aims: The dynamics of HBV viral load (VL) in patients with chronic hepatitis B (CHB) on nucleos(t)ide analogue (NA) treatment and its relationship with liver disease are poorly...
2.
Campbell C, Wang T, Smith D, Freeman O, Noble T, Varnai K, et al.
Wellcome Open Res
. 2024 May;
7:51.
PMID: 38721280
Background: To determine the impact of the COVID-19 pandemic on the population with chronic Hepatitis B virus (HBV) infection under hospital follow-up in the UK, we quantified the coverage and...
3.
Brendish N, Davis C, Chapman M, Borca F, Waddington D, Hill C, et al.
J Infect
. 2023 Nov;
88(1):41-47.
PMID: 37977337
Objectives: FebriDx is a CE-marked, FDA-approved point-of-care test that detects the antiviral host response protein Myxovirus Resistance Protein A (MxA), in addition to C-reactive protein, using finger-prick blood. FebriDx MxA...
4.
Hinton J, Augustine M, Gabara L, Mariathas M, Allan R, Borca F, et al.
J Intensive Care Soc
. 2023 Oct;
24(4):392-398.
PMID: 37841295
The aim of this study was to assess whether high sensitivity troponin (hs-cTnI) is associated with 1 year mortality in critical care (CC). One year mortality data were obtained from...
5.
Beard K, Borca F, Phan H, Brown E, Fenton P, Stansby J, et al.
J Infect
. 2023 Oct;
87(6):516-523.
PMID: 37802471
Objectives: COVID-19 has caused significant challenges for infection prevention measures and patient flow in hospital admission pathways. We aimed to assess the impact of replacing laboratory PCR with molecular point-of-care...
6.
Ardern-Jones M, Phan H, Borca F, Stammers M, Batchelor J, Reading I, et al.
PLoS One
. 2023 Jan;
18(1):e0280079.
PMID: 36649371
Background: The success of early dexamethasone therapy for hospitalised COVID-19 cases in treatment of Sars-CoV-2 infection may predominantly reflect its anti-inflammatory action against a hyperinflammation (HI) response. It is likely...
7.
Stammers M, Rahmany S, Downey L, Borca F, Harris C, Harris R, et al.
Frontline Gastroenterol
. 2022 Oct;
13(6):477-483.
PMID: 36250165
Introduction: Patients with suspected inflammatory bowel disease (IBD) referred from primary care often face diagnostic and treatment delays. This study aimed to compare a novel direct-access IBD endoscopy pathway with...
8.
Poole S, Tanner A, Naidu V, Borca F, Phan H, Saeed K, et al.
J Infect
. 2022 Sep;
85(6):625-633.
PMID: 36096312
Background: Effective treatment of pneumonia requires timely administration of appropriate antimicrobials but standard diagnostic tests take around 48 h to generate results. Highly accurate, rapid molecular tests have been developed...
9.
Mossotto E, Boberska J, Ashton J, Stafford I, Cheng G, Baker J, et al.
Sci Rep
. 2022 Aug;
12(1):14101.
PMID: 35982195
Crohn's disease (CD) is characterised by chronic inflammation. We aimed to identify a relationship between plasma inflammatory metabolomic signature and genomic data in CD using blood plasma metabolic profiles. Proton...
10.
Wang T, Smith D, Campbell C, Freeman O, Moysova Z, Noble T, et al.
Int J Epidemiol
. 2022 Jun;
52(1):e27-e37.
PMID: 35708657
No abstract available.